During the past decade, Hospital Universitario de Fuenlabrada conducted 109 clinical trials. In the 10-year time frame, 109 clinical trials started and 34 clinical trials were completed, i.e. on average, 31.2% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 26 clinical trials were completed. i.e. 68.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario de Fuenlabrada" #1 sponsor was "PETHEMA Foundation" with 13 trials, followed by "Eli Lilly and Company" with 8 trials sponsored, "Spanish Breast Cancer Research Group" with 8 trials sponsored, "Centro Nacional de Investigaciones Oncologicas CARLOS III" with 7 trials sponsored and "Pfizer" with 7 trials sponsored. Other sponsors include 98 different institutions and companies that sponsored additional 73 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario de Fuenlabrada" #1 collaborator was "Hospital Universitario de Fuenlabrada" with 6 trials as a collaborator, "Celgene" with 5 trials as a collaborator, "Apices Soluciones S.L." with 4 trials as a collaborator, "Gilead Sciences" with 4 trials as a collaborator and "Incyte Corporation" with 4 trials as a collaborator. Other collaborators include 139 different institutions and companies that were collaborators in the rest 122 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario de Fuenlabrada" are "Ulcerative Colitis" (15 trials), "Crohn's Disease" (9 trials), "Breast Cancer" (8 trials), "Inflammatory Bowel Diseases" (6 trials) and "Crohn Disease" (5 trials). Many other conditions were trialed in "Hospital Universitario de Fuenlabrada" in a lesser frequency.

Most popular intervention types in "Hospital Universitario de Fuenlabrada" are "Drug" (98 trials), "Other" (19 trials), "Biological" (8 trials), "Procedure" (7 trials) and "Device" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Dexamethasone" (6 trials), "Filgotinib" (6 trials), "Paclitaxel" (5 trials) and "Baricitinib" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario de Fuenlabrada" are 125 trials for "All" genders, 18 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 49 active trials in "Hospital Universitario de Fuenlabrada". 1 are not yet recruiting, 29 are recruiting, 18 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 79 completed trials in Hospital Universitario de Fuenlabrada, 1 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario de Fuenlabrada, 7 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 11 trials that are defined as “Not Applicable".

Hospital Universitario de Fuenlabrada has several departments that took part in Clinical trials: "Hospital Universitario de Fuenlabrada; Servicio de Oncologia" - 4 trials, "Hospital Universitario de Fuenlabrada, Servicio de Reumatologia" - 2 trials